Evolution of the Average Target: Lundbeck

Evolution of the Average Target - H. Lundbeck A/S

Evolution of the Target Price: Lundbeck

Evolution of the Target Price - Lundbeck

Changes in Analyst Recommendations: Lundbeck

431c.Y9IBKF1h5TU1NxP4kvRvKlwFesIYvTkR8CMocC6DJ1o.MbZPRhwKlFxZRHqzy9koYjJ_GbRhyGNCr25RRHbNEhw8pSxlBCS2TWBzVg~774bab925a32835febdad7b90973f7f5
30/09 H Lundbeck: Bold moves, blind spots Alphavalue
25/09 Danske Bank raises its price target for Lundbeck to 58 Danish kroner (57), reiterates buy - BN FW
21/09 UBS upgrades Lundbeck to buy (neutral), price target 52 Danish kroner (45) FW
15/09 Deutsche Bank still sees pressure on Lundbeck, cuts to sell FW
15/09 Deutsche Bank downgrades Lundbeck to sell (hold), target price 36 Danish kroner (40) FW
08/09 Barclays raises Lundbeck price target to 50 Danish kroner (48), reiterates equal weight - BN FW
24/08 Deutsche Bank sees higher costs for Lundbeck in the second half FW
20/08 Cancer vaccines finally garner the spotlight Alphavalue
20/08 UBS raises Lundbeck price target to 45 Danish kroner (44), reiterates neutral FW
19/08 H Lundbeck: Q2 beat, but pipeline execution remains non-negotiable Alphavalue
17/08 Lundbeck expected to report DKK 1,945m in adjusted EBITDA, consensus FW
17/07 Barclays raises price target for Lundbeck to 48 Danish kroner (45), reiterates equal weight - BN FW
14/07 Where would AI lead Pharma in the long run? Alphavalue
13/07 Danske Bank raises Lundbeck price target to 57 Danish kroner (55), reiterates buy - BN FW
18/06 Nordea raises target price for Lundbeck to DKK60 (57), reiterates buy rating FW
13/05 H Lundbeck: Strong Q1, but long-term growth uncertainty hovers over valuation Alphavalue
13/05 Nordea raises Lundbeck price target to DKK 57 (55), reiterates Buy FW
13/05 DNB Carnegie raises Lundbeck price target to DKK 54 (53), reiterates Buy FW
28/04 SEB raises Lundbeck price target to DKK 46 (43), reiterates Hold FW
27/04 UBS raises Lundbeck price target to DKK 44 (42), reiterates Neutral FW
23/03 H. Lundbeck Price Target Down as AlphaValue/Baader Europe Expects Patent Expirations to Weigh on Growth MT
20/03 H Lundbeck: Markets need more proof of growth promise Alphavalue
05/03 Nordea Resumes Coverage of Lundbeck With Buy Rating – Too Cheap to Ignore FW
05/03 Nordea Resumes Coverage of Lundbeck with Buy Rating and Price Target of 55 Danish Kroner FW
02/03 Jefferies Upgrades Lundbeck to Hold (Underperform), Sets Price Target at 39 Danish Kroner FW

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+11.82%
+8.2%
+3.47%
+9.45%
+4.35%
+4.69%
+30.29%
-5.23%
+8.46%
Average +8.39%
Weighted average by Cap. +8.80%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
45.08DKK
Average target price
49.19DKK
Spread / Average Target
+9.12%
High Price Target
65.00DKK
Spread / Highest target
+44.19%
Low Price Target
34.00DKK
Spread / Lowest Target
-24.58%

Analyst Consensus Detail

Analyst consensus - Lundbeck

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Lundbeck
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Lundbeck